drug
(fluticasone furoate + vilanterol trifenatate)
Marketedupdated 6mo agoby GlaxoSmithKline LLC
Approvedcommunity read0 votes
indications
investigational
COPDAsthma
all catalysts(0)
nothing on the calendar yet
Trials studying (fluticasone furoate + vilanterol trifenatate)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 13, 2026
16 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (24)
- Apr 11, 2031patentUS 8746242*PED4.5y
- Apr 11, 2031patentUS 8746242*PED4.5y
- Apr 11, 2031patentUS 8746242*PED4.5y
- Oct 11, 2030formulationUS 87462424.0y
- Oct 11, 2030formulationUS 87462424.0y
- Oct 11, 2030formulationUS 87462424.0y
- Sep 8, 2030patentUS 8534281*PED3.9y
- Sep 8, 2030patentUS 8534281*PED3.9y
- Sep 8, 2030patentUS 8534281*PED3.9y
- Mar 8, 2030formulationUS 85342813.4y
- Mar 8, 2030formulationUS 85342813.4y
- Mar 8, 2030formulationUS 85342813.4y
- Aug 26, 2029patentUS 11116721*PED2.8y
- Aug 26, 2029patentUS 11116721*PED2.8y
- Aug 26, 2029patentUS 11116721*PED2.8y
- Feb 26, 2029formulationUS 111167212.3y
- Feb 26, 2029formulationUS 111167212.3y
- Feb 26, 2029formulationUS 111167212.3y
- Dec 14, 2027patentUS 8511304*PED1.1y
- Dec 14, 2027patentUS 8511304*PED1.1y
- Dec 14, 2027patentUS 8511304*PED1.1y
- Jun 14, 2027formulationUS 8511304229d
- Jun 14, 2027formulationUS 8511304229d
- Jun 14, 2027formulationUS 8511304229d
FDA exclusivities (4)
- Nov 13, 2026PEDPediatric (6mo bonus)16d
- Nov 13, 2026PEDPediatric (6mo bonus)16d
- May 13, 2026NPPNew Product (3y)
- May 13, 2026NSNS
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 46m ago
Found something off?
comments(0)
5-min edit window · permanent after that